Mr. Doug Ward joined Personal Genome Diagnostics as Chief Executive Officer and a member of the board of directors in May 2016 from Roche, where he served as Vice President Companion Diagnostics (CDx) for Ventana Medical System. He has more than 25 years of experience within the diagnostic market and most recently has been responsible for creating Ventana’s CDx strategy, establishing Ventana’s innovative pharma partnering co-development business model, and achieving the market leading position in tissue based companion diagnostics. Prior to joining Roche, Mr. Ward served as President of the America’s Commercial Operations for GE Healthcare Life Sciences Business. Previously, he was Country Head of the UK and Ireland for Siemens Healthcare Diagnostics and Vice President of Marketing and Scientific Affairs for Bayer Diagnostics’ Molecular Diagnostics business unit. In addition, he has held leadership positions with Chiron Diagnostics and Ciba Corning Diagnostics. Doug received his BA from Ohio Wesleyan University in Pre-Medicine and Pre-Professional Zoology.

Tissue-based and liquid biopsy genomic products, Advanced cancer genome analysis, High-throughput next-generation sequencing